Related Experiment Video
Updated: Apr 27, 2026
Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Prolonged acute migraine with aura and reversible brain MRI abnormalities after liquid sclerotherapy
Yassine Zouitina, Mathilde Terrier, Marie Hyra
1Department of Neurology, Amiens University Hospital, 1 Place Victor Pauchet, F-80054 Amiens cedex, France. bugnicourt.jean-marc@chu-amiens.fr.
Abstract:
Transient visual disturbances constitute the most commonly reported neurological side effect during and immediately after sclerotherapy. A few studies, based on clinical and diffusion-weighted MRI assessments, have suggested that these transient neurological symptoms correspond to migraine with aura. Recently, it has been reported that brain magnetic resonance imaging can reveal transient T2*-weighted abnormalities during the acute phase of migraine with aura. We reported a 36-year-old man who presented with transient neurological symptoms and concomitant T2*-weighted abnormalities on brain magnetic resonance imaging immediately after liquid sclerotherapy. We hypothesize that the reversible nature of the patient's T2*-weighted abnormalities may indicate a relationship with the post-sclerotherapy migraine with aura attack.
Insights
Transient visual disturbances after sclerotherapy may be migraine with aura. Brain MRI revealed temporary T2*-weighted abnormalities, suggesting a link between sclerotherapy and migraine attacks.
Area of Science:
- Neurology
- Radiology
- Vascular Medicine
Background:
- Transient neurological symptoms are common after sclerotherapy.
- These symptoms are often suspected to be migraine with aura.
- Recent research indicates transient T2*-weighted MRI abnormalities in migraine with aura.
Observation:
- A 36-year-old man experienced transient neurological symptoms post-sclerotherapy.
- Brain MRI showed concurrent T2*-weighted abnormalities during the acute phase.
- The abnormalities were reversible, resolving with symptom resolution.
Findings:
- The patient's neurological symptoms and MRI findings align with migraine with aura.
- This case provides direct imaging evidence of potential neurological effects of sclerotherapy.
- The reversible T2*-weighted abnormalities suggest a transient ischemic or metabolic event.
Implications:
- Sclerotherapy may trigger migraine with aura in susceptible individuals.
- T2*-weighted MRI can be a valuable tool for diagnosing and understanding post-sclerotherapy neurological events.
- Further research is needed to elucidate the mechanism linking sclerotherapy and migraine with aura.
Related Concept Videos
01:21Imaging Studies for Cardiovascular System IV: CMRI
01:22Cerebral Edema ll: Pathophysiology